Medico-economic Evaluation of IMRT by Hi Art, RapidArc, VMAT Therapy in Prostate, Cervix and Anal Canal Cancers
NCT01325961 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 215
Last updated 2026-07-02
Summary
The aim of the study is a medico-economic evaluation to estimate a cost differential between three modalities of Intensity-Modulated Radiation Therapy for cancers of the prostate, cervix and anal canal with pelvic lymph node irradiation : treatment with helical Tomotherapy and dynamic arc therapy using two different technologies: RapidArc or VMAT.
Conditions
- Prostate Cancer
- Cervix Cancer
- Anal Canal Cancers
Interventions
- RADIATION
-
IMRT using Rapid Arc - prostate cancer
IMRT using Dynamic arc therapy by Rapid Arc technique for patients with prostate cancer
- RADIATION
-
IMRT using Rapid Arc - Anal canal cancer
IMRT using Dynamic arc therapy by Rapid Arc technique for patients with Anal canal cancer
- RADIATION
-
IMRT using Rapid Arc - Cervix cancer
IMRT using Dynamic arc therapy by Rapid Arc technique for patients with cervix cancer
- RADIATION
-
IMRT with HT - prostate cancer
IMRT using helical tomotherapy (HT) technique with prostate cancer
- RADIATION
-
IMRT with HT - Anal canal cancer
IMRT using helical tomotherapy (HT) technique with Anal canal cancer
- RADIATION
-
IMRT with HT - cervix cancer
IMRT using helical tomotherapy (HT) technique with cervix cancer
- RADIATION
-
IMRT with VMAT - prostate cancer
IMRT using Volumetric Modulated Arc Therapy (VMAT) with prostate cancer
- RADIATION
-
IMRT with VMAT - Anal canal cancer
IMRT using Volumetric Modulated Arc Therapy (VMAT) with Anal canal cancer
- RADIATION
-
IMRT with VMAT - cervix cancer
IMRT using Volumetric Modulated Arc Therapy (VMAT) with cervix cancer
Sponsors & Collaborators
-
Institut Cancerologie de l'Ouest
lead OTHER
Principal Investigators
-
Stéphane SUPIOT, MD, PhD · Institut de Cancérologie de l'Ouest
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-03-31
- Primary Completion
- 2015-05-31
- Completion
- 2020-02-29
Countries
- France
Study Locations
More Related Trials
-
Phase I-II Study on Treatment of Advanced Oropharynx Cancer in Elderly Population by Intensity Modulated Radiotherapy With Treatment Volume Reduction and Combination Chemotherapy
NCT01709006 ·Status: TERMINATED ·Phase: NA
-
3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Recurrent Tumors
NCT01470365 ·Status: COMPLETED ·Phase: PHASE1
-
Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) in Patients With Head and Neck Tumor
NCT00406289 ·Status: COMPLETED ·Phase: PHASE1
-
A Feasibility Study of Adaptive Intensity-Modulated Radiation Therapy
NCT00608751 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Evaluation of the Automatic Deformable Recontouring on the Daily MVCT for Head and Neck Cancer Adaptive Radiotherapy
NCT03953352 ·Status: WITHDRAWN ·Phase: NA
-
Whole Brain Radiotherapy Versus Volumetric Modulated Arc Therapy for Brain Metastases
NCT02220491 ·Status: COMPLETED ·Phase: NA
-
Protocole Advanced RadioTherapy ORL
NCT02024035 ·Status: COMPLETED
-
A Study of Conventional 3D Radiation vs. Intensity-Modulated Radiation in Squamous Cell Cancer of the Head and Neck
NCT00363441 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Hypofractionated Radiotherapy in Breast Cancer
NCT03167359 ·Status: COMPLETED ·Phase: NA
-
Consolidation Whole Abdominal Intensity-Modulated Radiation Therapy (IMRT) in Advanced Ovarian Cancer
NCT01180504 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase III Study Comparing 3D Conformal Radiotherapy and Conformal Radiotherapy IMRT to Treat Endometrial Cancer
NCT01641497 ·Status: TERMINATED ·Phase: NA
-
Helical Tomotherapy as a Radiotherapy Technique for Treating Pelvic and Abdominal Metastases
NCT00129051 ·Status: COMPLETED ·Phase: PHASE1
-
Trial to Investigate the Benefit of Elective Para-Aortic Radiotherapy (PART) for pN1 Prostate Cancer
NCT03079323 ·Status: RECRUITING ·Phase: PHASE2
-
Tomotherapy vs Conventional Radiation for Adjuvant Pelvic RT in Ca Cervix
NCT01279135 ·Status: COMPLETED ·Phase: PHASE3
-
Adaptative Radiotherapy to Decrease Xerostomia in Oropharynx Carcinoma
NCT01874587 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy
NCT01223248 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Comparison of Adaptive Dose Painting by Numbers With Standard Radiotherapy for Head and Neck Cancer.
NCT01341535 ·Status: COMPLETED ·Phase: PHASE2
-
Advanced Radiotherapy (ART) in Gynecological Cancer Patients (GYN-ART)
NCT06306170 ·Status: RECRUITING
-
Image Guided IMRT, Radiochemotherapy and MRI-based IGABT in Locally Advanced Cervical Cancer
NCT03617133 ·Status: RECRUITING ·Phase: PHASE2
-
A Phase II Single-arm Study of Total Body Irradiation With Linac Based VMAT and IGRT
NCT04509765 ·Status: COMPLETED ·Phase: NA
-
Pelvic IMRT With Tomotherapy in Post-Hysterectomy Endometrial Cancer Patients
NCT00334321 ·Status: COMPLETED ·Phase: PHASE1
-
Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy
NCT00508703 ·Status: COMPLETED
-
Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal Carcinoma
NCT02113423 ·Status: COMPLETED ·Phase: NA
-
Contribution of the ENT (Ear, Nose, and Throat) Surgeon's Clinical Evaluation to the Contouring of Target Volumes and Organs Eligible for Radiotherapy in Head and Neck Cancers
NCT03265873 ·Status: COMPLETED
-
A Phase II Multi-institutional Study Assessing Simultaneous In-field Boost Helical Tomotherapy for 1-3 Brain Metastases
NCT01543542 ·Status: COMPLETED ·Phase: PHASE2